These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29303526)

  • 21. Cis,cis,trans-[Pt
    Ravera M; Gabano E; Zanellato I; Rangone B; Perin E; Ferrari B; Bottone MG; Osella D
    Dalton Trans; 2021 Mar; 50(9):3161-3177. PubMed ID: 33595015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells.
    Yuan Y; Zhang CJ; Liu B
    Chem Commun (Camb); 2015 May; 51(41):8626-9. PubMed ID: 25898264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel hypoxia-targeting Pt(iv) prodrugs.
    Xu Z; Zhao J; Gou S; Xu G
    Chem Commun (Camb); 2017 Mar; 53(26):3749-3752. PubMed ID: 28303266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells.
    Maji M; Bhattacharya I; Acharya S; Chakraborty MP; Gupta A; Mukherjee A
    Inorg Chem; 2021 Apr; 60(7):4342-4346. PubMed ID: 33711231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
    Montagner D; Tolan D; Andriollo E; Gandin V; Marzano C
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance.
    Ma J; Li L; Yue K; Li Y; Liu H; Wang PG; Wang C; Wang J; Luo W; Xie S
    Bioorg Chem; 2020 Jun; 99():103768. PubMed ID: 32217375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
    Shi Y; Goodisman J; Dabrowiak JC
    Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S; Gandin V; Hoeschele JD; Marzano C; Natile G; Margiotta N
    Dalton Trans; 2018 May; 47(21):7144-7158. PubMed ID: 29766157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
    Min Y; Li J; Liu F; Yeow EK; Xing B
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
    Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
    Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supramolecular Photoactivatable Anticancer Hydrogels.
    Venkatesh V; Mishra NK; Romero-Canelón I; Vernooij RR; Shi H; Coverdale JPC; Habtemariam A; Verma S; Sadler PJ
    J Am Chem Soc; 2017 Apr; 139(16):5656-5659. PubMed ID: 28414222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines.
    Petruzzella E; Braude JP; Aldrich-Wright JR; Gandin V; Gibson D
    Angew Chem Int Ed Engl; 2017 Sep; 56(38):11539-11544. PubMed ID: 28759160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platinum(IV) Complexes of
    Papadia P; Micoli K; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
    Markova L; Maji M; Kostrhunova H; Novohradsky V; Kasparkova J; Gibson D; Brabec V
    J Med Chem; 2024 Jun; 67(11):9745-9758. PubMed ID: 38819023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
    Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailoring Platinum(IV) Amphiphiles for Self-Targeting All-in-One Assemblies as Precise Multimodal Theranostic Nanomedicine.
    He S; Li C; Zhang Q; Ding J; Liang XJ; Chen X; Xiao H; Chen X; Zhou D; Huang Y
    ACS Nano; 2018 Jul; 12(7):7272-7281. PubMed ID: 29906087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men.
    Gibson D
    ChemMedChem; 2021 Jul; 16(14):2188-2191. PubMed ID: 33928760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.